Ixabepilone in Treating Patients With Metastatic, Recurrent, or Unresectable Kidney Cancer

Clinical trial NCT00182702 · COMPLETED

Trial details

NCT number: NCT00182702
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Clear Cell Renal Cell Carcinoma Recurrent Renal Cell Cancer Stage III Renal Cell Cancer Stage IV Renal Cell Cancer

Start date: 2005-07-01
Primary completion: 2007-09-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.